BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Damas OM, Jahann DA, Reznik R, McCauley JL, Tamariz L, Deshpande AR, Abreu MT, Sussman DA. Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study. Am J Gastroenterol. 2013;108:231-239. [PMID: 23247580 DOI: 10.1038/ajg.2012.393] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Lin KK, Sewell JL. The effects of race and socioeconomic status on immunomodulator and anti-tumor necrosis factor use among ambulatory patients with inflammatory bowel disease in the United States. Am J Gastroenterol 2013;108:1824-30. [PMID: 24300857 DOI: 10.1038/ajg.2013.192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
2 Farrukh A, Mayberry J. Evidence of Differences and Discrimination in the Delivery of Care: Colorectal Screening in Healthy People and in the Care and Surveillance of Patients with Inflammatory Bowel Disease. GastrointestDisord 2019;1:253-60. [DOI: 10.3390/gidisord1020020] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Lattimer LDN, Chandler MB, Borum ML. Hispanics and Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2015;21:1214-8. [DOI: 10.1097/mib.0000000000000300] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Greywoode R, Petralia F, Ullman TA, Frederic Colombel J, Ungaro RC. Racial Difference in Efficacy of Golimumab in Ulcerative Colitis. Inflamm Bowel Dis 2022:izac161. [PMID: 35913121 DOI: 10.1093/ibd/izac161] [Reference Citation Analysis]
5 Tan MC, El-serag HB, Hou JK. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease. Dig Dis Sci 2017;62:607-14. [DOI: 10.1007/s10620-016-4414-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
6 Abreu-Delgado Y, Isidro RA, Torres EA, González A, Cruz ML, Isidro AA, González-Keelan CI, Medero P, Appleyard CB. Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease. World J Gastroenterol 2016; 22(13): 3581-3591 [PMID: 27053850 DOI: 10.3748/wjg.v22.i13.3581] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
7 Griffey RT, Fowler KJ, Theilen A, Gutierrez A. Considerations in Imaging Among Emergency Department Patients With Inflammatory Bowel Disease. Ann Emerg Med 2017;69:587-99. [PMID: 27317304 DOI: 10.1016/j.annemergmed.2016.04.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Barnes EL, Loftus EV Jr, Kappelman MD. Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases. Gastroenterology 2021;160:677-89. [PMID: 33098884 DOI: 10.1053/j.gastro.2020.08.064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
9 Afzali A, Cross RK. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences. Inflamm Bowel Dis 2016;22:2023-40. [PMID: 27379446 DOI: 10.1097/MIB.0000000000000835] [Cited by in Crossref: 56] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
10 Limketkai BN, Iheozor-Ejiofor Z, Gjuladin-Hellon T, Parian A, Matarese LE, Bracewell K, MacDonald JK, Gordon M, Mullin GE. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease. Cochrane Database Syst Rev 2019;2:CD012839. [PMID: 30736095 DOI: 10.1002/14651858.CD012839.pub2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
11 Barnes EL, Kochar B, Long MD, Martin CF, Kappelman MD. Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay. Inflamm Bowel Dis 2017;23:2189-96. [PMID: 29140942 DOI: 10.1097/MIB.0000000000001267] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
12 Damas OM, Gomez L, Quintero MA, Rampersaud E, Slifer S, Beecham GW, Kerman DH, Deshpande AR, Sussman DA, Abreu MT, McCauley JL. Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort. Clin Transl Gastroenterol 2017;8:e87. [PMID: 28406493 DOI: 10.1038/ctg.2017.13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
13 Odufalu FD, Aboubakr A, Anyane-Yeboa A. Inflammatory bowel disease in underserved populations: lessons for practice. Curr Opin Gastroenterol 2022;38:321-7. [PMID: 35762691 DOI: 10.1097/MOG.0000000000000855] [Reference Citation Analysis]
14 Gasparetto M, Guariso G. Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age. Gastroenterol Res Pract. 2013;2013:829040. [PMID: 24454343 DOI: 10.1155/2013/829040] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
15 Bhurwal A, Minacapelli CD, Patel A, Mutneja H, Goel A, Shah I, Bansal V, Brahmbhatt B, Das KM. Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities. Inflamm Bowel Dis 2021:izab020. [PMID: 33534892 DOI: 10.1093/ibd/izab020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hwang C, Velayos F. On the question of ethnicity and its impact on IBD-related outcomes. Dig Dis Sci 2014;59:19-21. [PMID: 24282056 DOI: 10.1007/s10620-013-2951-z] [Reference Citation Analysis]
17 Scaioli E, Liverani E, Belluzzi A. The Imbalance between n-6/n-3 Polyunsaturated Fatty Acids and Inflammatory Bowel Disease: A Comprehensive Review and Future Therapeutic Perspectives. Int J Mol Sci. 2017;18:2619. [PMID: 29206211 DOI: 10.3390/ijms18122619] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 10.6] [Reference Citation Analysis]
18 Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies. Clin Gastroenterol Hepatol 2018;16:190-197.e11. [PMID: 28603049 DOI: 10.1016/j.cgh.2017.05.047] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
19 Santos MPC, Gomes C, Torres J. Familial and ethnic risk in inflammatory bowel disease. Ann Gastroenterol. 2018;31:14-23. [PMID: 29333063 DOI: 10.20524/aog.2017.0208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
20 Lewis JD, Abreu MT. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. Gastroenterology. 2017;152:398-414.e6. [PMID: 27793606 DOI: 10.1053/j.gastro.2016.10.019] [Cited by in Crossref: 142] [Cited by in F6Publishing: 126] [Article Influence: 23.7] [Reference Citation Analysis]
21 Avalos DJ, Satiya J, Contreras A, Trivedi S, Alvarado L, Dodoo C, Dwivedi AK, Zuckerman MJ. Latin Americans and US Hispanics show differences in IBD phenotype: a systematic review with meta-analysis. J Investig Med 2021:jim-2021-001846. [PMID: 34933995 DOI: 10.1136/jim-2021-001846] [Reference Citation Analysis]
22 Liu JJ, Abraham BP, Adamson P, Barnes EL, Brister KA, Damas OM, Glover SC, Hooks K, Ingram A, Kaplan GG, Loftus EV, McGovern DPB, Narain-Blackwell M, Odufalu FD, Quezada S, Reeves V, Shen B, Stappenbeck TS, Ward L. The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients. Inflamm Bowel Dis 2022:izac124. [PMID: 35816130 DOI: 10.1093/ibd/izac124] [Reference Citation Analysis]
23 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205-217. [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34] [Cited by in Crossref: 816] [Cited by in F6Publishing: 710] [Article Influence: 116.6] [Reference Citation Analysis]
24 Zhornitskiy A, Shen S, Le LB, Fung BM, Zhornitsky F, Liang T, Limketkai BN, Sauk JS, Tabibian JH. Rates of inflammatory bowel disease in Hispanics comparable to non-Hispanic Whites: results of a cohort study. Int J Colorectal Dis 2021;36:1043-51. [PMID: 33410997 DOI: 10.1007/s00384-020-03819-0] [Reference Citation Analysis]
25 Damas OM, Avalos DJ, Palacio AM, Gomez L, Quintero MA, Deshpande AR, Sussman DA, McCauley JL, Lopez J, Schwartz SJ, Abreu MT. Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba. Aliment Pharmacol Ther 2017;46:303-9. [PMID: 28524546 DOI: 10.1111/apt.14145] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
26 Maldonado-Contreras A. Food as Treatment of Inflammatory Bowel Diseases. Infect Immun 2022;:e0058321. [PMID: 35323020 DOI: 10.1128/iai.00583-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Farrukh A, Mayberry J. Apparent discrimination in the provision of biologic therapy to patients with Crohn's disease according to ethnicity. Public Health 2015;129:460-4. [DOI: 10.1016/j.puhe.2015.01.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
28 Juliao-Baños F, Kock J, Arrubla M, Calixto O, Camargo J, Cruz L, Hurtado J, Clavijo A, Donado J, Schwartz S, Abreu MT, Damas OM. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients. Medicine (Baltimore) 2021;100:e24729. [PMID: 33607817 DOI: 10.1097/MD.0000000000024729] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Farrukh A, Mayberry J. Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England. GastrointestDisord 2020;2:144-51. [DOI: 10.3390/gidisord2020015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
30 Stallwood C, Shergill K, Wu J, Farraye FA, Miller HL. Manifestations of inflammatory bowel disease in patients of Haitian and Cape Verdean descent. Scand J Gastroenterol 2015;50:832-40. [PMID: 25652938 DOI: 10.3109/00365521.2015.1008034] [Reference Citation Analysis]
31 Hiroz P, Vavricka SR, Fournier N, Safroneeva E, Pittet V, Rogler G, Schoepfer AM; on behalf of the Swiss Inflammatory Bowel Diseases Cohort Study Group*. Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort. Scandinavian Journal of Gastroenterology 2014;49:1207-18. [DOI: 10.3109/00365521.2014.946082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
32 Sariahmed K, Kurian J, Singh AK, Leyton C, Minuti A, Jerschow E, Arora S, Jariwala SP. Social, political, and economic determinants of access to biologics: A scoping review of structural determinants in the clinical disparities literature. Research in Social and Administrative Pharmacy 2022. [DOI: 10.1016/j.sapharm.2022.07.047] [Reference Citation Analysis]
33 Spekhorst LM, Severs M, de Boer NKH, Festen EAM, Fidder HH, Hoentjen F, Imhann F, de Jong DJ, van der Meulen-de Jong AE, Pierik MJ, van der Woude CJ, Dijkstra G, Ponsioen CY, Löwenberg M, Oldenburg B, Weersma RK; on behalf of the Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis. The Impact of Ethnicity and Country of Birth on Inflammatory Bowel Disease Phenotype: a Prospective Cohort Study. Journal of Crohn's and Colitis 2017;11:1463-70. [DOI: 10.1093/ecco-jcc/jjx098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
34 Barnes EL, Nowell WB, Venkatachalam S, Dobes A, Kappelman MD. Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States. Inflamm Bowel Dis 2021:izab219. [PMID: 34473272 DOI: 10.1093/ibd/izab219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Damas OM, Estes D, Avalos D, Quintero MA, Morillo D, Caraballo F, Lopez J, Deshpande AR, Kerman D, McCauley JL, Palacio A, Abreu MT, Schwartz SJ. Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease. Dig Dis Sci 2018;63:3058-66. [PMID: 29982988 DOI: 10.1007/s10620-018-5185-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
36 El Mouzan MI, AlEdreesi MH, Hasosah MY, Al-Hussaini AA, Al Sarkhy AA, Assiri AA. Regional variation of pediatric inflammatory bowel disease in Saudi Arabia: Results from a multicenter study. World J Gastroenterol 2020; 26(4): 416-423 [PMID: 32063690 DOI: 10.3748/wjg.v26.i4.416] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65:100851. [PMID: 30837080 DOI: 10.1016/j.disamonth.2019.02.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 16.7] [Reference Citation Analysis]
38 Avalos DJ, Mendoza-ladd A, Zuckerman MJ, Bashashati M, Alvarado A, Dwivedi A, Damas OM. Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis. Dig Dis Sci 2018;63:1558-71. [DOI: 10.1007/s10620-018-5022-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
39 Misra R, Faiz O, Munkholm P, Burisch J, Arebi N. Epidemiology of inflammatory bowel disease in racial and ethnic migrant groups. World J Gastroenterol 2018; 24(3): 424-437 [PMID: 29391765 DOI: 10.3748/wjg.v24.i3.424] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
40 Abelson JS, Michelassi F, Mao J, Sedrakyan A, Yeo H. Higher Surgical Morbidity for Ulcerative Colitis Patients in the Era of Biologics. Ann Surg 2018;268:311-7. [PMID: 28448381 DOI: 10.1097/SLA.0000000000002275] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 7.7] [Reference Citation Analysis]
41 Farrukh A, Mayberry JF. Ethnic variations in the provision of biologic therapy for Crohn's disease: a Freedom of Information study. Med Leg J 2015;83:104-8. [DOI: 10.1177/0025817214563907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Isidro RA, Cruz ML, Isidro AA, Baez A, Arroyo A, González-Marqués WA, González-Keelan C, Torres EA, Appleyard CB. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia. World J Gastroenterol 2015; 21(6): 1749-1758 [PMID: 25684939 DOI: 10.3748/wjg.v21.i6.1749] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]